The Senate Appropriations Committee included a $2 billion increase for the National Institutes of Health in their Fiscal Year 2018 bill, however Congress voted to pass a three-month Continuing Resolution (CR), which will keep NIH and NCI at flat funding through December 8, 2017.
ASCO in Action regularly provides the latest news and analysis related to cancer policy news; see the following online articles. These updates provide snapshots of ASCO’s ongoing advocacy efforts, as well as opportunities for ASCO members and guests to take action on critical issues affecting the cancer community.
To sign up for advocacy alerts, log in to ASCO.org with your ASCO member or guest account, and visit the subscription center available under your account profile.
On July 19, the House Appropriations Committee voted to advance legislation to provide a $1.1 billion increase to the National Institutes of Health (NIH). Given the funding environment on Capitol Hill, it’s unlikely the appropriations bill passed by the Committee will be signed into law-as is.
The National Institutes of Health (NIH) recently announced the Next Generation Researcher Initiative, which is designed to increase funding to early-stage and mid-career researchers.
ASCO congratulates Francis S. Collins, MD, PhD, on the announcement of his continued service as the Director of the National Institutes of Health (NIH). A renowned researcher and skilled administrator, Dr. Collins appreciates the critical role that federal research plays in advancing our understanding of how to prevent, diagnose, and treat cancer and other life-threatening diseases, and has worked tirelessly to ensure that the United States remains at the forefront of biomedical innovation.
ASCO was on Capitol Hill with the American Association for Cancer Research (AACR) and the Association of American Cancer Institutes (AACI) to advocate for robust federal research funding.
Congress passed a Continuing Resolution to fund the federal government through May 5, 2017. The Continuing Resolution includes flat funding for the National Institutes of Health (NIH) and other government agencies and programs.
Lawmakers expressed their concerns with proposed cuts to the National Institutes of Health (NIH) during hearings on Capitol Hill.
The U.S. cancer care delivery system is undergoing profound changes to better meet the needs of people with cancer, but persistent hurdles threaten to slow progress, according to ASCO's fourth annual State of Cancer Care in America report released March 22, 2017.
ASCO submitted written testimony asking Congress to increase federal support for the National Institutes of Health (NIH) and the Beau Biden Cancer Moonshot Initiative in fiscal year 2018 (FY18).
With the new Congress and Administration in place, ASCO has been on Capitol Hill monitoring the issues that affect the cancer care community, and educating lawmakers on how best to serve Americans with cancer. In particular, ASCO is closely tracking efforts to repeal and replace the Affordable Care Act (ACA), the discussion on the future of Medicaid, and relevant cabinet appointments.
ASCO has submitted comments to the National Institutes of Health (NIH) in response to a Request for Information (RFI) on data sharing and management (NOT-OD-17-015).